Berger Montague Investigates Hims & Hers Health Inc. (HIMS) for Securities Fraud Following Termination of Novo Nordisk Partnership

Philadelphia, Pennsylvania--(Newsfile Corp. - June 27, 2025) - Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Investor Deadline: Investors who purchased or acquired Hims & Hers securities between April 29, 2025 and June 22, 2025 (the “Class Period”) may, no later than August 25, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights,CLICK HERE. On June 23, 2025, Novo Nordisk announced the...